Literature DB >> 4992997

Immunological basis of the adenovirus 8-9 cross-reaction.

J C Hierholzer, W R Dowdle.   

Abstract

The dedecon and hexon components of adenovirus types 8 and 9 have been extensively purified for use in establishing the basis of the cross-reaction between these types. Dodecons, the complete hemagglutinins, were purified 304- to 362-fold by fluorocarbon extraction, calcium phosphate batch chromatography, and ion-exchange column chromatography. Hexons, the group complement-fixation (CF) antigens, were purified 230- to 240-fold by erythrocyte adsorption, ion-exchange chromatography, and exclusion chromatography. Component antisera prepared in rabbits were tested in reciprocal fashion with crude virus and dodecon and hexon components. By hemagglutination-inhibition (HI), the dodecons of types 8 and 9 demonstrated the same predominantly one-sided relationship characteristic of the crude antigens. Some neutralizing activity was associated with both dodecons and hexons of each type. However, combining anti-dodecon and anti-hexon sera or producing antisera against the combined dodecon-hexon components resulted in neutralizing titers which were identical to titers obtained with antisera against the crude virus harvests. Dedecons of each type appear to share at least one antigenic determinant with hexons of the same type, and this determinant may reside on the vertex capsomere. Hexons possess group- and type-specific determinants, as shown by CF, neutralization, and immunodiffusion tests, and may exhibit some minor relationship between types 8 and 9. The results with the purified components are consistent with the predominantly one-sided antigenic relationship between types 8 and 9 in the conventional HI tests and the largely type-specific relationship by neutralization tests.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4992997      PMCID: PMC376195     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  The relationship between soluble antigens and the virion of adenovirus type 3. 3. Immunological identification of fiber antigen and isolated vertex capsomer antigen.

Authors:  E Norrby; P Skaaret
Journal:  Virology       Date:  1967-07       Impact factor: 3.616

2.  Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen.

Authors:  U Pettersson; L Philipson; S Höglund
Journal:  Virology       Date:  1967-12       Impact factor: 3.616

3.  Role of adenovirus antigens in the induction of virus neutralizing antibody.

Authors:  L Kjellén; H G Pereira
Journal:  J Gen Virol       Date:  1968-01       Impact factor: 3.891

4.  The relationship between the soluble antigens and the virion of adenovirus type 3. IV. Immunological complexity of soluble components.

Authors:  E Norrby
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

5.  [Serological relationship of group II adenoviruses].

Authors:  R Wigand
Journal:  Arch Gesamte Virusforsch       Date:  1968

6.  The serological relationship of the soluble antigens of adenovirus type 19.

Authors:  H Gelderblom; W Meiser; A Lengyel; R Wigand
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

7.  [Type-specific antigens of adenovirus].

Authors:  W Meiser; J Lange; D Loytved; R Wigand
Journal:  Arch Gesamte Virusforsch       Date:  1969

8.  Comparative studies on the soluble components of adenovirus types 9 and 15 and the intermediate strain 9-15.

Authors:  E Norby
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

9.  Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes.

Authors:  D A Stevens; M Schaeffer; J P Fox; C D Brandt; M Romano
Journal:  Am J Epidemiol       Date:  1967-11       Impact factor: 4.897

10.  The structure of group II adenoviruses.

Authors:  H Gelderblom; H Bauer; H Frank; R Wigand
Journal:  J Gen Virol       Date:  1967-10       Impact factor: 3.891

View more
  15 in total

1.  Serological and genetic characterisation of a unique strain of adenovirus involved in an outbreak of epidemic keratoconjunctivitis.

Authors:  A K Adhikary; T Inada; U Banik; A Mukouyama; Y Ikeda; M Noda; T Ogino; E Suzuki; T Kaburaki; J Numaga; N Okabe
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  Molecular characterization of the type-specific gamma-determinant located on the adenovirus fiber.

Authors:  B Eiz; P Pring-Akerblom
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

3.  Production and evaluation of a purified adenovirus group-specific (hexon) antigen for use in the diagnostic complement fixation test.

Authors:  W R Dowdle; M Lambriex; J C Hierholzer
Journal:  Appl Microbiol       Date:  1971-04

4.  Neutralization of adenovirus toxins: specificity and antigenic relationships.

Authors:  N Döring; C X Nguyen; R Wigand
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

5.  Immunological relationship among human adenoviruses of subgenus D.

Authors:  R Wigand; D Keller; I Werling
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity.

Authors:  W A Volk; R M Synder; D C Benjamin; R R Wagner
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

7.  Antigenically intermediate human adenovirus strain associated with conjunctivitis.

Authors:  J C Hierholzer; F H Rodriguez
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

8.  Vero microcultures for adenovirus neutralization tests.

Authors:  J C Hierholzer; P G Bingham
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

9.  Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers.

Authors:  J C Hierholzer; W C Gamble; W R Dowdle
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

10.  New human adenovirus isolated from a renal transplant recipient: description and characterization of candiate adenovirus type 34.

Authors:  J C Hierholzer; N O Atuk; J M Gwaltney
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.